局部非类固醇抗炎药物治疗急性肌肉骨疼痛
Sheena Derry1, Philip Wiffen1, Andrew Moore1
1Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England.
JAMA
|February 24, 2016
概括
局部非类固醇抗炎药物 (NSAIDs) 有效地减少急性肌肉骨损伤的疼痛,例如扭伤和扭伤. 与安慰剂相比,这些疗法可以缓解更多的疼痛,但不会显著增加不良反应.
科学领域:
- 药理学
- 肌肉骨医学
- 治疗疼痛
背景情况:
- 急性肌肉骨疾病 (扭伤,伤) 是常见的疼痛原因.
- 局部非类固醇抗炎药物 (NSAID) 是一种局部治疗选择.
研究的目的:
- 评估局部NSAID在急性肌肉骨疾病中减轻疼痛强度的有效性.
- 评估局部NSAID的安全性,特别是寻找与安慰剂相比增加的不良事件.
主要方法:
- 随机对照试验的系统审查和元分析.
- 对急性肌肉骨损伤的局部NSAID与安慰剂的比较
- 评估疼痛强度得分和不良事件报告.
主要成果:
- 与安慰剂相比,局部NSAID显示疼痛强度有显著的降低.
- 在局部使用NSAID时,没有观察到不良事件发生率的显著增加.
结论:
- 在急性肌肉骨疾病中,局部NSAID有效缓解疼痛.
- 局部NSAID是一种安全的治疗选择,副作用的概况与安慰剂相比较.
相关概念视频
Analgesia and Pain Management
2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K
Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.5K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.4K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K
Classification of Skeletal Muscle Relaxants
3.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K
Spasmolytic Agents: Chemical Classification
1.4K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.4K


